Jialing Zhou

976 total citations
39 papers, 382 citations indexed

About

Jialing Zhou is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Jialing Zhou has authored 39 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 30 papers in Hepatology and 2 papers in Surgery. Recurrent topics in Jialing Zhou's work include Liver Disease Diagnosis and Treatment (31 papers), Hepatitis B Virus Studies (31 papers) and Hepatitis C virus research (22 papers). Jialing Zhou is often cited by papers focused on Liver Disease Diagnosis and Treatment (31 papers), Hepatitis B Virus Studies (31 papers) and Hepatitis C virus research (22 papers). Jialing Zhou collaborates with scholars based in China, Singapore and United States. Jialing Zhou's co-authors include Hong You, Jidong Jia, Xiaoning Wu, Yameng Sun, Yuanyuan Kong, Xiaojuan Ou, Shanshan Wu, Bingqiong Wang, Shuyan Chen and Na Zeng and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Jialing Zhou

34 papers receiving 374 citations

Peers

Countries citing papers authored by Jialing Zhou

Since Specialization

Citations

This map shows the geographic impact of Jialing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jialing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jialing Zhou more than expected).

Fields of papers citing papers by Jialing Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jialing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jialing Zhou. The network helps show where Jialing Zhou may publish in the future.

Co-authorship network of co-authors of Jialing Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jialing Zhou. A scholar is included among the top collaborators of Jialing Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jialing Zhou. Jialing Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serological proteomic characterization for monitoring liver fibrosis regression in chronic hepatitis B patients on treatment 2025 ·Nature Communications ·Mengyang Zhang, Shuyan Chen, Xiaoning Wu, Jialing Zhou, Bingqiong Wang, (unknown), Rongxuan Hua, Yameng Sun, Hong You, Wei Chen	0
2	Application of random survival forest to establish a nomogram combining clinlabomics-score and clinical data for predicting brain metastasis in primary lung cancer 2024 ·Clinical & Translational Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Xin Lin, Yangyang Cheng, (unknown), Jialing Zhou, (unknown), (unknown), Hongxia Zhang, Yihua Sun	2
3	Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments 2024 ·Hepatology International ·Shuyan Chen, Jialing Zhou, Xiaoning Wu, (unknown), Bingqiong Wang, Hui Liu, Tailing Wang, Xinyan Zhao, (unknown), Yuanyuan Kong, Xiaojuan Ou, Jidong Jia, Yameng Sun, Hong You	3
4	Calcium-sensing receptor and NF-κB pathways in TN breast cancer contribute to cancer-induced cardiomyocyte damage via activating neutrophil extracellular traps formation 2024 ·Cellular and Molecular Life Sciences ·(unknown), Yangyang Cheng, (unknown), (unknown), Chenglong Ding, (unknown), Baohong Cui, Yixin Chen, Song Gao, Siwen Zhang, Kaiyue Liu, Yue Lu, Jialing Zhou, (unknown), (unknown)	9
5	Long‐term antiviral therapy is associated with changes in the profile of transcriptionally active HBV integration in the livers of patients with CHB 2024 ·Journal of Medical Virology ·Xiajie Wen, Xiaoning Wu, Yameng Sun, Jialing Zhou, Guiwen Guan, Shuyan Chen, Shan Shan, Hong Ma, Xinyan Zhao, Yu Wang, Xiaojuan Ou, Hong You, Ju‐Tao Guo, Fengmin Lu, Jidong Jia	3
6	Magnetron sputtered transition-metal-nitrides thin films as electrode materials for supercapacitors: A review 2024 ·Journal of Energy Storage ·Jialing Zhou, (unknown), Jian Wang	10
7	Multiple Low‐Level Viraemia Suggest Hindered Liver Fibrosis Regression in Chronic Hepatitis B Patients During Antiviral Therapy 2024 ·Journal of Viral Hepatitis ·(unknown), Yameng Sun, Shuyan Chen, (unknown), Bingqiong Wang, Jialing Zhou, (unknown), Xinyan Zhao, (unknown), Xiaojuan Ou, (unknown), Jidong Jia, Xinyu Zhao, (unknown)	1
8	Dynamic changes in three biomarkers predict early-stage hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy 2023 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Jialing Zhou, Hongyi Li, Hui Wang, Jiangbo Ren, Shujie Sun, (unknown), Shanshan Wu, Ming Cao, Kaixiang Wang, Hong You, Hong Ma	1
9	Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients 2023 ·Clinical and Molecular Hepatology ·Xiaoning Wu, (unknown), Jialing Zhou, Yameng Sun, Huiguo Ding, Wen Xie, Guofeng Chen, Anlin Ma, Hongxin Piao, Bingqiong Wang, Shuyan Chen, (unknown), Xiaojuan Ou, Hwai‐I Yang, Jidong Jia, Yuanyuan Kong, Hong You	6
10	A new glutamine synthetase index to evaluate hepatic lobular restoration in advanced fibrosis during anti‐HBV therapy 2023 ·Journal of Medical Virology ·Shuyan Chen, Bingqiong Wang, Jialing Zhou, Xiaoning Wu, (unknown), Hui Liu, Tailing Wang, Xinyan Zhao, Shanshan Wu, Yuanyuan Kong, Xiaojuan Ou, Jidong Jia, Aileen Wee, Hong You, Yameng Sun	0
11	Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding 2023 ·Hepatology International ·Zhiying He, Bingqiong Wang, Xiaoning Wu, Zhongjie Hu, Chunqing Zhang, (unknown), Yongfeng Yang, Yan Huang, Wei Rao, Jing Wang, Jialing Zhou, (unknown), Xiaojuan Ou, Jidong Jia, Hong You	4
12	Distinct on-treatment HCC risks associated with different decompensation events in HBV patients with cirrhosis 2023 ·Hepatology International ·Yuanyuan Kong, Yameng Sun, Xiaoning Wu, Jialing Zhou, Hao Wang, Huiguo Ding, Wen Xie, Guofeng Chen, Anlin Ma, Hongxin Piao, Xiaoyuan Xu, Wei Jiang, Bo Feng, Xiaojuan Ou, Hong You, Samuel S. Lee, Jidong Jia	2
13	Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis 2021 ·Hepatology International ·Xiaoning Wu, (unknown), Jialing Zhou, Yameng Sun, Lei Li, Wen Xie, Hongxin Piao, Xiaoyuan Xu, Wei Jiang, Bo Feng, Yongpeng Chen, Mingyi Xu, Jilin Cheng, (unknown), Bingqiong Wang, Shuyan Chen, Yuanyuan Kong, Xiaojuan Ou, Hong You, Jidong Jia	11
14	Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy 2020 ·Clinical Gastroenterology and Hepatology ·Yameng Sun, Xiaoning Wu, Jialing Zhou, (unknown), Bingqiong Wang, Shuyan Chen, Hui Liu, Tailing Wang, Xinyan Zhao, Shanshan Wu, Yuanyuan Kong, Xiaojuan Ou, Aileen Wee, Neil D. Theise, Chao Qiu, Wenhong Zhang, Fengmin Lu, Jidong Jia, Hong You	72
15	<p>Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study</p> 2019 ·Infection and Drug Resistance ·Xiaoning Wu, Jialing Zhou, Wen Xie, Huiguo Ding, Xiaojuan Ou, Guofeng Chen, Anlin Ma, Xiaoyuan Xu, Hui Ma, Youqing Xu, Xiaoqing Liu, (unknown), Lin Wang, Yameng Sun, Bingqiong Wang, Yuanyuan Kong, Hong Ma, Hong You, Jidong Jia	8
16	SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies 2019 ·Hepatology International ·Bingqiong Wang, Yameng Sun, Jialing Zhou, Xiaoning Wu, Shuyan Chen, Yiwen Shi, Shanshan Wu, Hui Liu, Yayun Ren, Xiaojuan Ou, Jidong Jia, Hong You	11
17	Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak “stable” patients on anti-HBV therapy 2018 ·Scientific Reports ·Yameng Sun, Jialing Zhou, Xiaoning Wu, Yongpeng Chen, Hongxin Piao, Lungen Lu, Huiguo Ding, Yuemin Nan, Wei Jiang, Tailing Wang, Hui Liu, Xiaojuan Ou, Aileen Wee, Neil D. Theise, Jidong Jia, Hong You	32
18	Systematic review: diagnostic accuracy of non-invasive tests for staging liver fibrosis in autoimmune hepatitis 2018 ·Hepatology International ·Shanshan Wu, Zhirong Yang, Jialing Zhou, Na Zeng, Zhiying He, Siyan Zhan, Jidong Jia, Hong You	41
19	Platelets’ increase is associated with improvement of liver fibrosis in entecavir-treated chronic hepatitis B patients with significant liver fibrosis 2018 ·Hepatology International ·Lin Wang, Bingqiong Wang, Hong You, Xiaoning Wu, Jialing Zhou, Xiaojuan Ou, Jidong Jia	12
20	Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients 2018 ·Modern Pathology ·Bingqiong Wang, Yameng Sun, Jialing Zhou, Xiaoning Wu, Shuyan Chen, Shanshan Wu, Hui Liu, Tailing Wang, Xiaojuan Ou, Jidong Jia, Hong You	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact